The Member of Parliament for Agotime-Ziope, Charles Agbeve, has thrown his support behind the government’s $50 million investment in the National Vaccine Institute, describing it as a critical step toward strengthening Ghana’s health security and building local vaccine manufacturing capacity.Speaking on the floor of Parliament of Ghana in Accra, the MP said the initiative would help reduce Ghana’s reliance on imported vaccines while advancing the country’s goal of achieving vaccine sovereignty.According to him, the investment is expected to create new opportunities for local pharmaceutical manufacturing, scientific research, and job creation, positioning Ghana as a future vaccine production hub in the region.“This milestone represents a historic breakthrough,” Agbeve told the House, emphasizing that the initiative will strengthen the country’s preparedness against future public health emergencies.He also highlighted strategic partnerships between the National Vaccine Institute and international firms including Atlantic Life Sciences and PT Bio Farma for technology transfer.The collaboration, he explained, is expected to enable Ghana to produce its first locally manufactured vaccine—Tetanus-Diphtheria—after nearly seven decades, marking a significant step in rebuilding the country’s vaccine production capacity.Agbeve urged Ghanaians and stakeholders to support the initiative, noting that it could transform the country into a regional vaccine manufacturing hub in West Africa while strengthening national health resilience.